VALN -Valneva Tick Ticker 💰🪲

Investor summaryBullish

Valneva's Lyme disease vaccine is in Phase 3 with 70% efficacy amid rising tick populations, making it a potential moonshot.

Bull points

Lyme disease cases are rising significantly (40% increase this year), driving demand for a vaccine.
The vaccine is already in Phase 3 trials with a promising 70% efficacy rate.

VALN逼空 / Meme

Post body

For those of you who don’t know Valneva (VALN) is working on a vaccine for Lyme disease which is a tick borne illness.

Not sure if you have been living under a rock 🪨 but the tick population has been rising year after year 📈

With a 40% increase in Lyme disease cases this year alone.

Meaning the appetite for a vaccine is increasing and they are already in stage 3 of releasing the vaccine which currently has a 70% efficacy rate.

In plain English VALN has potential to go to the moon so buy ur tick ticker ticket to the moon while u can. 🚀

TLDR: tick go boom u go moon (not financial advice)

Discussion · top comments

No comment snapshot fetched for this post yet.